Literature DB >> 8259166

Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome.

G S Tint1, M Irons, E R Elias, A K Batta, R Frieden, T S Chen, G Salen.   

Abstract

BACKGROUND: The Smith-Lemli-Opitz syndrome (frequency, 1:20,000 to 1:40,000) is defined by a constellation of severe birth defects affecting most organ systems. Abnormalities frequently include profound mental retardation, severe failure to thrive, and a high infant-mortality rate. The syndrome has heretofore been diagnosed only from its clinical presentation.
METHODS: Using capillary-column gas chromatography-mass spectrometry, we measured the sterol composition of plasma, erythrocytes, lens, cultured fibroblasts, and feces from five children with the syndrome (three girls and two boys).
RESULTS: Plasma cholesterol levels were abnormally low (8 to 101 mg per deciliter [0.20 to 2.60 mmol per liter]) in every patient, being well below the 5th percentile for age- and sex-matched controls. Concentrations of the cholesterol precursor 7-dehydrocholesterol (cholesta-5,7-dien-3 beta-ol), which was not detectable in most of our controls, were elevated (11 to 31 mg per deciliter) more than 2000-fold above normal and were similar to the levels of cholesterol in all tissues from all patients. An isomeric dehydrocholesterol with a structure similar to that of 7-dehydrocholesterol was also detected.
CONCLUSIONS: The combination of abnormally low plasma cholesterol levels and a high concentration of the cholesterol precursor 7-dehydrocholesterol points to a major block in cholesterol biosynthesis at the step in which the C-7(8) double bond of 7-dehydrocholesterol is reduced, forming cholesterol. The block may be sufficient to deprive an embryo or fetus of cholesterol and prevent normal development, whereas the incorporation of 7-dehydrocholesterol into all membranes may interfere with proper membrane function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259166     DOI: 10.1056/NEJM199401133300205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  178 in total

1.  Characterization of the biochemical abnormality in the Smith-Lemli-Opitz syndrome.

Authors:  A K Batta; G Salen
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

2.  Serum lipids and apolipoproteins in children with the Smith-Lemli-Opitz syndrome.

Authors:  D Behúlová; V Bzdúch; J Skodová; A Dello Russo; G Corso; J Ponec; A Kasanická
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

3.  Smith-Lemli-Opitz syndrome: molecular-genetic analysis of ten families.

Authors:  L Kozák; H Francová; E Hrabincová; D Procházková; V Jüttnerová; V Bzdúch; P Simek
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

Review 4.  The sonic hedgehog-patched-gli pathway in human development and disease.

Authors:  E H Villavicencio; D O Walterhouse; P M Iannaccone
Journal:  Am J Hum Genet       Date:  2000-09-21       Impact factor: 11.025

Review 5.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

6.  Diagnosis of Smith-Lemli-Opitz syndrome from stored filter paper blood specimens.

Authors:  L Starck; A Lövgren
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

7.  Blocking cholesterol synthesis impairs acquisition of the classically conditioned eyeblink response.

Authors:  W T O'Brien; G Xu; G S Tint; G Salen; R J Servatius
Journal:  Integr Physiol Behav Sci       Date:  2000 Apr-Jun

8.  Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells.

Authors:  Libin Xu; Zeljka Korade; Dale A Rosado; Karoly Mirnics; Ned A Porter
Journal:  J Lipid Res       Date:  2013-02-04       Impact factor: 5.922

9.  Molecular screening of Smith-Lemli-Opitz syndrome in pregnant women from the Czech Republic.

Authors:  I Blahakova; E Makaturova; L Kotrbova; M Soukupova; J Lastuvkova; L Kozak
Journal:  J Inherit Metab Dis       Date:  2007-11-12       Impact factor: 4.982

10.  Clinical utility gene card for: Smith-Lemli-Opitz Syndrome [SLOS].

Authors:  Martina Witsch-Baumgartner; Hilary Sawyer; Dorothea Haas
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.